1. Brown WD, Oakes TR, DeJesus OT, Taylor MD, Roberts AD, Nickles RJ, Holden JE (1998) Fluorine-18-fluoro-L-DOPA dosimetry with carbidopa pretreatment. J Nucl Med 39:1884–1891
2. Chroustova D, Trnka J, Pudlac A, Obermannova B, Lambert L (2020) The role of (18)F-DOPA PET/CT in the diagnosis of the congenital focal form of hyperinsulinism in children. Rev Esp Med Nucl Imagen Mol (Engl Ed) 39:279–283
3. Eisenhofer G, Friberg P, Rundqvist B, Quyyumi AA, Lambert G, Kaye DM, Kopin IJ, Goldstein DS, Esler MD (1996) Cardiac sympathetic nerve function in congestive heart failure. Circulation 93:1667–1676
4. Eldrup E, Richter AE, Christensen NJ (1989) Dopa, norepinephrine, and dopamine in rat tissues: no effect of sympathectomy on muscle dopa. Am J Physiol 256:E284–E287
5. Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I, Cheshire WP, Chelimsky T, Cortelli P, Gibbons CH, Goldstein DS, Hainsworth R, Hilz MJ, Jacob G, Kaufmann H, Jordan J, Lipsitz LA, Levine BD, Low PA, Mathias C, Raj SR, Robertson D, Sandroni P, Schatz I, Schondorff R, Stewart JM, van Dijk JG (2011) Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res 21:69–72